ID: ALA4525319

Max Phase: Preclinical

Molecular Formula: C12H11N3O2

Molecular Weight: 229.24

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1ccc(-n2cc(C3CC3)nn2)cc1

Standard InChI:  InChI=1S/C12H11N3O2/c16-12(17)9-3-5-10(6-4-9)15-7-11(13-14-15)8-1-2-8/h3-8H,1-2H2,(H,16,17)

Standard InChI Key:  HQISMWGSCAGFHS-UHFFFAOYSA-N

Associated Targets(non-human)

ORF 73 309 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 229.24Molecular Weight (Monoisotopic): 229.0851AlogP: 1.84#Rotatable Bonds: 3
Polar Surface Area: 68.01Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.52CX Basic pKa: 0.17CX LogP: 2.25CX LogD: -0.55
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.87Np Likeness Score: -1.55

References

1. Kirsch P, Jakob V, Oberhausen K, Stein SC, Cucarro I, Schulz TF, Empting M..  (2019)  Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8.,  62  (8): [PMID:30888817] [10.1021/acs.jmedchem.8b01827]

Source